approval
saveWEGOVY (SEMAGLUTIDE) — FDA approval
December 22, 2025updated 5mo ago
community read0 votes
Sponsor: NOVO. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalNov 21, 2025
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalJan 29, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalJan 29, 2026
- approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalJan 30, 2026
- recallProRx LLC recall (Cls II)Nov 5, 2025
- recallProRx LLC recall (Cls II)Nov 5, 2025
🐶 often sniffed alongside
top 7- companyNovo Nordisk Inc2 co-mentions · 2 sources
- tagHepatology2 co-mentions · 1 sources
- tagObesity2 co-mentions · 1 sources
- tagEndocrinology & Metabolism1 co-mentions · 1 sources
- drugObesity1 co-mentions · 1 sources
- drugzalfermin1 co-mentions · 1 sources
- drugcagrilintide hydrochloride1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that